Coventry University Featured PhD Programmes
Birkbeck, University of London Featured PhD Programmes
University of Kent Featured PhD Programmes
University of Sussex Featured PhD Programmes
University of Reading Featured PhD Programmes

Targeting the EML4-NEK9-NEK7 complex in drug-resistant EML4-ALK lung cancer

Project Description

PhD Start date: September 2020

Lung cancer is the largest cause of cancer-related deaths. While little progress has been made in long-term survival rates, we now have a good understanding of the genetic drivers. 5% of lung cancers are driven by the EML4-ALK oncogenic fusion and these initially respond well to targeted ALK inhibition. However, patients inevitably relapse and there is a need for new therapeutic approaches. We have discovered an ALK-independent pathway that drives metastatic dissemination of these cancers. This involves formation of a complex between EML4 and the NEK9 and NEK7 kinases. In this PhD project, we will first use a structural biology approach to map interacting domains and define the molecular nature of the EML4-NEK9-NEK7 complex. Second, we will use molecular cell biology techniques to test for the presence of this complex in tumour samples and whether ALK inhibitors or approaches that inactivate NEK9 and NEK7 prevent downstream changes that drive metastasis.

Academic entry requirements:
UK Bachelor Degree with at least 2:1 in a relevant subject or overseas equivalent.

How to apply:
Standard application:

UK and EU candidates only

Funding Notes

Funding Source: College studentship

Funding will cover stipend (at Research Council rates)

3-year tuition fee waiver

Email Now

Insert previous message below for editing? 
You haven’t included a message. Providing a specific message means universities will take your enquiry more seriously and helps them provide the information you need.
Why not add a message here
* required field
Send a copy to me for my own records.

Your enquiry has been emailed successfully

FindAPhD. Copyright 2005-2019
All rights reserved.